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Abstract
Background: The importance of intra-abdominal pressure (IAP) and abdominal perfusion pressure (APP) in cirrhotic
patients with septic shock is not well studied. We evaluated the relationship between IAP and APP and outcomes
of cirrhotic septic patients, and assessed the ability of these measures compared to other common resuscitative
endpoints to differentiate survivors from nonsurvivors.
Methods: This study was a post hoc analysis of a randomized double-blind placebo-controlled trial in which mean
arterial pressure (MAP), central venous oxygen saturation (ScvO2) and IAP were measured every 6 h in 61 cirrhotic
septic patients admitted to the intensive care unit. APP was calculated as MAP - IAP. Intra-abdominal hypertension
(IAH) was defined as mean IAP ≥ 12 mmHg, and abdominal hypoperfusion as mean APP < 60 mmHg. Measured
outcomes included ICU and hospital mortality, need for renal replacement therapy (RRT) and ventilator- and
vasopressor-free days.
Results: IAH prevalence on the first ICU day was 82%, and incidence in the first 7 days was 97%. Compared to
patients with normal IAP, IAH patients had significantly higher ICU mortality (74.0% vs. 27.3%, p = 0.005), required
more RRT (78.0% vs. 45.5%, p = 0.06) and had lower ventilator- and vasopressor-free days. On a multivariate logistic
regression analysis, IAH was an independent predictor of both ICU mortality (odds ratio (OR), 12.20; 95%
confidence interval (CI), 1.92 to 77.31, p = 0.008) and need for RRT (OR, 6.78; 95% CI, 1.29 to 35.70, p = 0.02). Using
receiver operating characteristic curves, IAP (area under the curve (AUC) = 0.74, p = 0.004), APP (AUC = 0.71, p =
0.01), Acute Physiology and Chronic Health Evaluation II score (AUC = 0.71, p = 0.02), but not MAP, differentiated
survivors from nonsurvivors.
Conclusions: IAH is highly prevalent in cirrhotic patients with septic shock and is associated with increased ICU
morbidity and mortality.
Background
Cirrhotic patients with septic shock (SS) represent a
unique group with different presentation, pathophysiol-
ogy and prognosis compared to other critically ill
patients [1-6]. Because of the presence of ascites [7],
which is often complicated by spontaneous bacterial
peritonitis [8], increased intra-abdominal pressure (IAP)
occurs frequently in these patients. Studies have demon-
strated that intra-abdominal hypertension (IAH) is com-
mon in critically ill patients [9,10] and is associated with
multiple organ dysfunction [11-14] and increased mor-
tality [15]. Additionally, liver dysfunction is a significant
IAH risk factor in these patients [16]. In cirrhotic
patients, Luca et al. found that mechanically increasing
IAP in 14 patients with portal hypertension led to dele-
terious effects such as increased azygos blood flow and
decreased cardiac output and hepatic blood flow [17].
However, little is known about the clinical significance
of IAH in critically ill cirrhotic patients. Moreover, it is
not clear whether abdominal perfusion pressure (APP)
is a good resuscitation endpoint in cirrhotics.
Therefore, we studied the occurrence of IAH in cir-
rhotic patients admitted with SS both on admission and
during the intensive care unit stay and assessed its
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provided the original work is properly cited.association with mortality. The ability of IAP and APP
compared to other commonly used resuscitation end-
points to differentiate survivors from nonsurvivors was
also assessed.
Methods
Patients and setting
This study was conducted in a 21-bed closed medical-
surgical ICU of a tertiary care hospital with an active
liver transplant service. The ICU was staffed 24/7 by
board-certified intensivists. In 2007, there were 1,118
ICU admissions with a mean Acute Physiology and
Chronic Health Evaluation (APACHE) II score [18] of
24.4 and an APACHE II-adjusted standardized mortality
ratio of 0.97. This study was a post hoc analysis of a ran-
domized double-blinded placebo-controlled trial that
studied the effect of low-dose hydrocortisone on the
outcomes of cirrhotic patients admitted to the ICU with
SS. The trial, performed between April 2004 and Octo-
ber 2007, included 75 adult patients and was approved
by the hospital’s Institutional Review Board [19]. It
excluded patients who had hypovolemic or hemorrhagic
shock, known adrenal insufficiency, prior steroid use or
contraindication for steroids [19]. It showed that hydro-
cortisone improved hemodynamics, but not mortality,
and was associated with increased side effects [19]. The
current study included the 61 patients who had repeated
IAP measurements.
IAP measurement
The standard method for indirectly measuring IAP is to
measure the intra-vesicular pressure [20]. For the clini-
cal trial, IAP was measured by trained critical care
nurses using the modified Kron technique [21] every 6
h for up to 7 days after ICU admission. Briefly, the blad-
der drainage system was clamped just distal to the con-
nection of the urinary catheter to the drainage bag. An
18-gauge needle was then inserted into the sampling
port and connected via a sterile tube to the pressure
transducer using two three-way stopcocks. A standard
infusion bag of normal saline was attached to one stop-
cock, and a 60-ml syringe was connected to the second
stopcock. Sterile saline (50 to 100 ml) was injected into
the bladder. Measurements were taken at end-expiration
while patients were in complete supine position and
with the transducer zeroed at the symphysis pubis level.
Patient management
Patients were managed using a goal-directed therapy for
the treatment of septic shock [22]. This entailed achiev-
ing mean arterial pressure (MAP) ≥ 65 mmHg, central
venous pressure (CVP) ≥ 8 mmHg and central venous
oxygen saturation (ScvO2) ≥ 70% using fluids, vasopres-
sors, inotropes and/or blood transfusion. No goals were
set for IAP and APP such that the management of IAH
was left to the discretion of the attending intensivist.
IAH definitions
The World Society of the Abdominal Compartment
Syndrome (http://www.wsacs.org), in its latest consensus
statement [23], defined IAH as sustained or repeated
IAP of ≥ 12 mmHg. Likewise, abdominal compartment
syndrome (ACS) was defined as IAP > 20 mmHg in
combination with at least one new end-organ failure,
which can be identified by a Sequential Organ Failure
Assessment (SOFA) sub-score ≥ 3 [23]. In this study, we
calculated the mean of the first four IAP measurements
done on each of the first 7 days of ICU stay. Patients
with IAP ≥ 1 2m m H gw e r ec o n s i d e r e dt oh a v eI A H .
Those with IAP ≥ 20 mmHg were considered to have
ACS. In addition, APP was calculated by subtracting
IAP from simultaneous MAP measurements. Mean APP
< 60 mmHg was considered abnormal [24].
Collected data
We collected the following demographic and clinical
information: age, gender, body mass index, liver cirrho-
sis etiology, Child-Pugh score, admission APACHE II
score, SOFA [25], presence of ascites on physical exam,
diagnosis of spontaneous bacterial peritonitis and hepa-
tic encephalopathy on ICU admission, admission hemo-
globin, albumin, serum lactate, creatinine, bilirubin and
ammonia, international normalized ratio (INR), the ratio
of the partial pressure of arterial oxygen to the fraction
of inspired oxygen (PaO2/FiO2) and requirement for
mechanical ventilation. We also extracted data on MAP,
CVP, ScvO2, IAP and APP.
Outcome measures
The primary outcome measure was ICU mortality. The
secondary outcomes were hospital mortality, ventilator-
free days, vasopressor-free days, duration of mechanical
ventilation, ICU and hospital length of stay and the
need for renal replacement therapy (RRT), including
continuous veno-venous hemofiltration or intermittent
hemodialysis. RRT was initiated at the discretion of the
attending intensivist in consultation with the nephrology
department.
Statistical analysis
Data were analyzed using SAS software (version 8.0;
SAS Institute, Cary, NC, USA). Continuous data were
presented as mean with standard deviation (SD),
whereas categorical ones were summarized as absolute
and relative frequencies (percent). Demographic and
physiologic variables were compared among the differ-
ent IAP groups using the Student’s t test or chi square/
Fisher’s exact test based on whether the variable was
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regression was used to study IAH predictors with the
following independent variables: APACHE II score, pre-
sence of ascites and of encephalopathy, mechanical ven-
tilation, number of transfused PRBC units on day 1, net
fluid balance on day 1, INR and bilirubin. To examine
the association between IAP and APP and different end-
points, we used multivariate logistic regression analysis
to adjust for the following variables: age, APACHE II,
Child-Pugh score, requirement for mechanical ventila-
tion, creatinine, INR, fluid balance on day 1 and hydro-
cortisone therapy. Moreover, the ability of IAP and APP
to discriminate survivors from nonsurvivors was com-
pared to other standard hemodynamic endpoints (MAP
and ScvO2) and APACHE II using the receiver operating
characteristic (ROC) curves. Youden index was calcu-
lated to assess the best IAP and APP cut-offs that discri-
minate survivors from non survivors [26]. Additionally,
survival analysis was performed using Kaplan-Meier
curves to examine the time-dependent mortality differ-
ence stratified by different hemodynamic targets (MAP
≥ 65 and < 65 mmHg, ScvO2 ≥ 70% and < 70% and IAP
and APP ≥ and < the best cut-offs on the ROC curve
analysis).
Results
Prevalence and incidence of IAH and characteristics of
the patients according to IAH
The studied patients had the following characteristics
(Table 1): age = 59.0 ± 13.0 years, 58% were men, hepatitis
C was the most common cause of cirrhosis (44%) with
mean Child-Pugh score of 11.6 and most patients had
ascites (94%) and hepatic encephalopathy (76%). All
patients were on vasopressors, and most (90%) required
mechanical ventilation. On the first ICU admission day,
mean IAP was 16.7 ± 3.9 mmHg, with 50 patients (82%)
having IAH, and 9 patients (15%) having ACS. In addition,
70% of patients had mean APP < 60 mmHg. During the
first 7 days of ICU stay, 97% of patients developed IAH,
and 39% had ACS.
The characteristics of the study population according
to IAP (< 12 vs. ≥ 12 mmHg) and APP (< 60 vs. ≥ 60
mmHg) are shown in Table 1. On the stepwise logistic
regression analysis, none of the studied variables was
associated with IAH, including fluid balance on day 1
(OR, 1.28/l increment; 95% CI, 0.90 to 1.81).
Hemodynamic endpoints
Figure 1 describes four hemodynamic indices (MAP,
ScvO2, IAP and APP) observed in the first 7 days of ICU
admission. Whereas MAP ≥ 65 mmHg and ScvO2 ≥ 70%
were achieved in most patients (e.g., 86% and 77% of
patients, respectively, on day 2), IAP < 12 mmHg and
APP ≥ 60 mmHg were present in fewer patients (23%
and 36%, respectively, on day 2). ICU survivors and non-
survivors had similar day 1 ScvO2 (75 ± 8% and 78 ±
11%, respectively, p =0 . 3 5 )a n dM A P( 7 1±7m m H gv s .
70 ± 7 mmHg, respectively, p = 0.42). On the other hand,
ICU survivors had significantly lower day 1 IAP (13 ±
4 mmHg vs. 16 ± 5 mmHg, p =0 . 0 1 5 )a n dh i g h e rA P P
(59 ± 7 mmHg vs. 54 ± 8 mmHg, p = 0.02) compared to
nonsurvivors.
Relationship between IAH and outcomes
The ICU and hospital mortality for all patients were
65.6% and 88.5%, respectively. Table 2 describes the out-
comes of patients according to the presence or absence
of IAH on the first ICU day. Although the ICU length
of stay was similar in both groups, IAH patients had sig-
nificantly fewer vasopressor- and ventilator-free days
than the non-IAH group and tended to require RRT
more often (78.0% vs. 45.5%, p = 0.06). ICU mortality
was almost three times higher in the IAH group (74.0%
vs. 27.3%, p = 0.005). However, the hospital mortality
was not statistically different between the two groups
(92.0% vs. 72.7%, p = 0.10). The association between
APP and outcomes followed a similar pattern but was
not statistically different. Figure 2 describes the evolu-
tion of SOFA, ScvO2,I A Pa n dA P Pi nI C Us u r v i v o r s
and nonsurvivors during ICU stay, and shows clear
separation for the SOFA score, APP and, to a lesser
extent, IAP, but not ScvO2.
For patients with IAP < 12 mmHg, ICU mortality was
50.0% for the hydrocortisone-treated group compared to
14.3% for the placebo group, p = 0.49. In IAH patients,
ICU mortality was 64.3% for the hydrocortisone-treated
patients compared to 86.4% for the placebo group, p =
0.08. Randomization to either hydrocortisone or placebo
did not affect ICU mortality for patients with APP < or
≥ 60 mmHg.
IAP and APP as predictors of outcomes
Stepwise multivariate logistic regression analysis (Table 3)
showed that IAH was significantly associated with
increased ICU mortality (OR, 12.20; 95% CI, 1.92 to 77.31,
p = 0.008) and need for RRT (OR, 6.78; 95% CI, 1.29 to
35.70, p = 0.02), but not hospital mortality (OR, 6.83; 95%
CI, 0.86 to 54.12, p = 0.07). The relationship between
abdominal hypoperfusion (APP < 60 mmHg) and various
outcomes did not reach statistical significance (Table 3).
Resuscitation indices as predictors of ICU mortality
Figure 3 shows the ROC curves of four resuscitation
indices (MAP, ScvO2, IAP and APP) and APACHE II.
Of the four indices, only IAP and APP had significant
discrimination (areas under the curve 0.74 [95% CI, 0.58
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whereas MAP and ScvO2 did not. IAP = 12.4 mmHg
and APP = 54.7 mmHg were found to be the cut-offs
with the highest calculated Youden index (0.38 and 0.36,
respectively) and, hence, the best to discriminate survi-
vors from nonsurvivors.
Figure 4 describes the Kaplan-Meier curves of patients
having the following resuscitation indices on the first
ICU day (MAP ≥ 65 vs. < 65 mmHg, ScvO2 ≥ 70% vs. <
70%, IAP ≥ 12 vs. < 12 mmHg and APP ≥ 55 vs. < 55
mmHg) and shows the presence of a significant survival
difference based on IAP < 12 vs. ≥ 12 mmHg.
Discussion
The main findings of this study were the following: IAH
was common in cirrhotic patients presenting with SS;
IAH was an independent predictor for the need for RRT
and of ICU mortality, and finally, IAP discriminated bet-
ter between survivors and nonsurvivors than MAP and
ScvO2.
Table 1 Characteristics of patients according to mean IAP and APP on the first ICU admission day.
All patients IAP
a <1 2
mmHg
IAP
a ≥ 12
mmHg
p
value
APP
a ≥ 60
mmHg
APP
a <6 0
mmHg
p value
N =6 1 N =1 1 N =5 0 N =1 8 N =4 3
Age in years, mean ± SD 59.8 ± 12.2 63.6 ± 7.4 59.0 ± 13.0 0.26 59.0 ± 14.2 60.2 ± 11.5 0.74
Male sex, N (%) 36 (59.0) 7 (63.7) 29 (58.0) 1.00 7 (38.9) 18 (41.9) 0.83
Body mass index (Kg/m
2), mean ± SD 26.8 ± 5.9 26.5 ± 6.3 26.9 ± 5.9 0.87 26.3 ± 6.5 27.0 ± 5.8 0.70
Etiology of liver cirrhosis, N (%)
Hepatitis C 30 (49.2) 8 (73.0) 22 (44.0) 7 (39.0) 23 (53.0)
Hepatitis B 17 (27.9) 2 (18.0) 15 (30.0) 0.27 6 (33.0) 11 (26.0) 0.56
Others 14 (23.0) 1 (9.0) 13 (26.0) 5 (28.0) 9 (21.0)
Child-Pugh score, mean ± SD 11.6 ± 1.6 11.2 ± 1.4 11.6 ± 1.6 0.39 11.2 ± 1.9 11.7 ± 1.4 0.29
APACHE II score, mean ± SD 30.1 ± 7.5 23.9 ± 7.7 31.5 ± 6.7 0.002 29.9 ± 7.8 30.2 ± 7.4 0.91
SOFA score, mean ± SD 14.9 ± 3.7 12.5 ± 4.5 15.4 ± 3.3 0.02 13.9 ± 3.7 15.3 ± 3.7 0.1
SOFA renal sub-score 2.2 ± 1.4 2.0 ± 1.7 2.3 ± 1.3 0.52 1.7 ± 1.4 2.5 ± 1.3 0.06
SBP, N (%) 19 (31.1) 7 (63.6) 12 (24.0) 0.03 5 (27.8) 14 (32.6) 0.71
Encephalopathy, N (%) 42 (68.9) 4 (36.4) 38 (76.0) 0.03 11 (61.1) 31 (72.1) 0.28
Ascites, N (%) 58 (95.1) 11 (100) 47 (94.0) 0.05 16 (88.9) 42 (97.7) 0.26
Mechanically ventilated, N (%) 51 (83.6) 6 (54.5) 45 (90.0) 0.01 16 (88.9) 35 (81.4) 0.71
PaO2/FiO2 ratio (mmHg), mean ± SD 252 ± 141 261 ± 129 250 ± 144 0.83 194 ± 117 277 ± 144 0.04
Norepinephrine dose at inclusion (μg/kg/
min), mean ± SD
0.35 ± 0.35 0.20 ± 0.29 0.39 ± 0.35 0.11 0.26 ± 0.34 0.39 ± 0.35 0.21
Creatinine
b (μmol/l), mean ± SD 289 ± 165 299 ± 176 286 ± 165 0.81 239 ± 147 309 ± 170 0.13
INR, mean ± SD 2.8 ± 1.4 2.6 ± 1.5 2.8 ± 1.4 0.71 2.4 ± 0.7 2.9 ± 1.6 0.08
Bilirubin
b (μmol/l), mean ± SD 340.3 ± 284.3 146.0 ± 193.5 383.1 ± 284.6 0.01 313.3 ± 305.2 351.7 ± 278.1 0.63
Ammonia
b (μmol/l), mean ± SD 110.2 ± 101.1 74.7 ± 41.1 118.0 ± 108.8 0.03 111.6 ± 167.2 109.6 ± 57.4 0.96
Albumin (g/l), mean ± SD 32.5 ± 7.1 33.8 ± 8.1 32.2 ± 6.9 0.50 31.5 ± 5.4 32.9 ± 7.7 0.48
Hemoglobin (g/dl), mean ± SD 8.6 ± 1.6 9.4 ± 1.6 8.4 ± 1.6 0.27 8.3 ± 1.5 8.7 ± 1.6 0.42
Lactate level
b (mmol/l), mean ± SD 4.4 ± 4.3 3.7 ± 4.6 4.5 ± 4.2 0.59 2.9 ± 2.2 5.0 ± 4.8 0.02
Fluid intake in day 1 (ml), mean ± SD 4,356 ± 2,574 3,993 ± 1,877 4,436 ± 2,712 0.61 4,015 ± 2,486 4,499 ± 3,336 0.51
Fluid balance in day 1 (ml), mean ± SD 3,177 ± 2,919 1,544 ± 2,980 3,537 ± 4,335 0.04 2,368 ± 2,913 3,516 ± 2,887 0.16
MAP day 1 (mmHg), mean ± SD 70.7 ± 7.2 58.8 ± 5.8 59.4 ± 8.1 0.83 63.3 ± 7.1 57.6 ± 7.3 0.007
CVP day 1 (mmHg), mean ± SD 15.5 ± 6.2 12.3 ± 4.0 16.2 ± 6.4 0.054 14.1 ± 6.5 16.1 ± 6.1 0.28
IAP day 1 (mmHg), mean ± SD 15.3 ± 4.7 9.0 ± 2.2 16.7 ± 3.9 <
0.0001
12.8 ± 3.8 16.3 ± 4.7 0.008
APP day 1 (mmHg), mean ± SD 55.5 ± 7.7 59.4 ± 6.2 54.6 ± 7.8 0.06 64.7 ± 5.4 51.6 ± 4.7 < 0.0001
Randomization, N (%)
Hydrocortisone 32 (52.5) 4 (36.4) 28 (56.0) 0.24 14 (77.8) 18 (41.9) 0.01
Placebo 29 (47.5) 7 (63.6) 22 (44.0) 4 (22.2) 25 (58.1)
IAP ≥ 12 mmHg indicates intra-abdominal hypertension, and APP < 60 mmHg indicates abdominal hypoperfusion. IAP, intra-abdominal pressure; APP, abdominal
perfusion pressure; SD, standard deviation; APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment; SBP,
spontaneous bacterial peritonitis; MAP, mean arterial pressure; CVP, central venous pressure; INR, international normalized ratio; PaO2/FiO2, the ratio of the partial
pressure of arterial oxygen (PaO2) to the fraction of inspired oxygen (FiO2).
aMean values on the first ICU day.
bTo convert creatinine to mg/dl, divide by 88.4;
bilirubin to mg/dl, divide by 17.1; ammonia to μg/dl, divide by 0.587; lactic acid to mg/dl, divide by 0.111.
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scarce. One study showed that mechanically increasing
IAP by 10 mmHg in 14 patients with portal hypertension
led to a reduction in hepatic blood flow by 20% (p < 0.05)
[17]. Another study found that increased IAP leads to an
increase in variceal pressure, radius, volume and wall
tension, which may trigger variceal bleeding [27]. These
findings suggest that increased IAP contributes to acute
decompensation of liver function and to various cirrho-
sis-related complications, which support our findings.
In this study, IAH was defined as mean IAP ≥ 12
mmHg at which physiologic and clinical derangements
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Figure 1 Day-by-day percentages of cirrhotic patients with septic shock.W i t hm e a na r t e r i a lp r e s s u r e≥ 65 mmHg vs. < 65 mmHg (A),
central venous oxygen saturation ≥ 70% vs. < 70% (B), intra-abdominal pressure ≥ 12 mmHg vs. < 12 mmHg (C) and abdominal perfusion
pressure ≥ 60 mmHg vs. < 60 mmHg (D) in the first 7 days of intensive care unit stay.
Table 2 Outcomes of cirrhotic patients with septic shock according to the occurrence of intra-abdominal hypertension
and abdominal hypoperfusion.
IAP
a < 12 mmHg IAP
a 1 ≥ 12 mmHg p value APP
a ≥ 60 mmHg APP
a < 60 mmHg p value
N =1 1 N =5 0 N =1 8 N =4 3
ICU mortality, N (%) 3 (27.3) 37 (74.0) 0.005 9 (50) 31 (72.1) 0.10
Hospital mortality, N (%) 8 (72.7) 46 (92.0) 0.10 15 (83.3) 39 (90.7) 0.41
Duration of MV in days, mean ± SD 4.8 ± 7.5 8.2 ± 6.7 0.14 9.6 ± 7.1 8.9 ± 6.4 0.70
Ventilator-free days, mean ± SD 15.3 ± 11.4 4.7 ± 7.2 0.01 7.4 ± 8.7 6.3 ± 9.2 0.65
Vasopressor-free days, mean ± SD 10.5 ± 8.4 4.6 ± 7.1 0.02 8.4 ± 8.6 4.5 ± 7.1 0.07
ICU LOS (days), mean ± SD 11.1 ± 8.0 9.8 ± 6.0 0.56 11.0 ± 6.7 9.6 ± 6.2 0.45
Hospital LOS (days), mean ± SD 31.1 ± 16.8 21.1 ± 14.6 0.05 23.6 ± 10.3 22.7 ± 17.1 0.81
Requirement for RRT, N (%) 5 (45.5) 39 (78) 0.06 11 (61.1) 33 (76.7) 0.21
RRT-free days, mean ± SD 10.8 ± 12.7 5.0 ± 7.5 0.17 7.4 ± 8.9 5.5 ± 8.8 0.44
IAP ≥ 12 mmHg indicates intra-abdominal hypertension, and APP < 60 mmHg indicates abdominal hypoperfusion. IAP, intra-abdominal pressure; APP, abdominal
perfusion pressure; RRT, renal replacement therapy; MV, mechanical ventilation; LOS, length of stay.
aMean values on the first ICU day.
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an indicator of abdominal hypoperfusion as this pressure
has been shown to correlate well with survival from IAH
and ACS [28]. This followed the recommendation of the
International Conference of Experts on Intra-abdominal
Hypertension and Abdominal Compartment Syndrome
[24]. We found that 82% of cirrhotic patients with SS
had IAH, and most patients (70%) had reduced APP (<
60 mmHg) on the first ICU admission day. This is
higher than the IAH prevalence in general ICU patients
and could be explained by the high prevalence of ascites
in cirrhotics. A multicenter, prospective one-day point-
prevalence study conducted in 13 ICUs of six countries
demonstrated that IAH was present in > 50% of all sur-
gical and medical critically ill patients hospitalized for >
24 h [9]. Interestingly, we found that most patients with
spontaneous bacterial peritonitis (64%) had normal IAP.
This may be explained by the fact that these patients
might have undergone therapeutic and diagnostic
abdominal paracentesis before ICU admission.
Whether IAH is a marker of illness severity or a cause
of critical illness or clinical deterioration remains
unclear. Malbrain et al. found that the development of
IAH during ICU stay, and not IAH at ICU admission,
was a risk factor for mortality in a general population of
critically ill patients [16]. In our study, IAH on admis-
sion was associated with a higher APACHE II score but
was also a strong independent predictor of the need for
RRT and ICU mortality on multivariate logistic regres-
sion analysis. The potential pathophysiologic changes
responsible for these effects are multiple. Various
organs, inside and outside the abdomen, can be
adversely affected by increased IAP [12]. For example,
IAH is associated with increased intracranial pressure
[29], cardiac dysfunction [30], respiratory failure [31],
splanchnic hypoperfusion [13] and acute renal insuffi-
ciency [32]. These are probably the results of mechani-
cal and nonmechanical effects of increased IAP [33]. In
association with massive fluid resuscitation, the acute
intestinal permeability syndrome, which is part of global
A. 
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Figure 2 Evolution of the different variables studied. Sequential organ failure assessment score (A), central venous oxygen saturation (B),
intra-abdominal pressure (C) and abdominal perfusion pressure (D) during the first 7 days of intensive care unit stay in ICU survivors and
nonsurvivors. Error bars represent standard deviations.
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Page 6 of 11capillary leak, may lead to multi-organ failure [33]. In
addition, IAH is associated with a proinflammatory state
[28]. In a study of ten rats, IAH of 20 mmHg caused a
significant increase in tumor necrosis factor a and inter-
leukin-6 after 30 min and an increase in interleukin-1b
after 60 min [28]. This state may serve as a second
insult for the development of multiple organ failure. Of
note, IAH was significantly associated with ICU, but not
hospital mortality. Explanations include that ICU survi-
vors had advanced cirrhosis and died later during hospi-
talization because of disease progression with or without
Do-Not-Resuscitate orders, or did not receive liver
transplantation because of organ shortage or being unfit.
Additionally, because our study included the first ICU
admission only, the ICU mortality represents the first
ICU admission mortality, while hospital mortality
includes mortality during all ICU admissions and ward
admissions.
Because of the adverse effects of IAH on various
organs, lowering IAP and using APP as a resuscitation
endpoint appear to be appealing management strategies.
A retrospective study of 144 surgical patients treated for
IAH (IAP ≥ 15 mmHg) with resuscitation and, if needed,
with open abdominal decompression surgery found that
APP was able to discriminate survivors from nonsurvi-
vors better than MAP and lactate [34]. In our study, the
ROC curves showed that IAP and APP, but not MAP or
ScvO2, predicted survival, raising the question whether
IAP and APP are better resuscitative endpoints than the
traditional ones. The ROC curve analysis also suggested
that IAP < 12 mmHg and APP > 55 mmHg should be
considered therapeutic targets in cirrhotics with SS.
Additionally, we found that, in most patients in whom
traditional resuscitative endpoints were achieved (MAP ≥
65 mmHg, ScvO2 ≥ 70%), IAP and APP were not.
Achieving the target MAP and ScvO2 alone might not be
enough in this population.
IAH management is recommended in critically ill
patients [24] even though strong evidence of its benefit
remains lacking. A prospective observational study of
478 consecutive surgical patients requiring an open
abdomen for the management of IAH or ACS showed a
significant decrease in hospital mortality after the imple-
mentation of a comprehensive management algorithm
for IAH and ACS [35]. In 23 cirrhotic patients with
hepatorenal syndrome, infusion of 200 ml of 20%
human albumin solution followed by large-volume
abdominal paracentesis resulted in IAP reduction from
a median of 22 to 9 mmHg and a significant increase in
creatinine clearance during the subsequent 12 h from 23
ml/min to 33 ml/min (p = 0.002) [36]. Moreover, creati-
nine clearance remained elevated for up to several days
afterwards [36]. Medical interventions that have been
suggested to treat IAH include sedation, neuromuscular
blockade, gastric or colonic decompression, hypertonic
fluids or colloids, forced diuresis and hemofiltration
Table 3 Stepwise multivariate logistic regression analysis for three outcomes: mortality in the ICU, hospital and need
for RRT.
Variable Intra-abdominal hypertension Variable Abdominal hypoperfusion
Odds ratio 95% Confidence interval Odds ratio 95% Confidence interval
ICU mortality
Intra-abdominal hypertension 12.20 1.92 to 77.31 Abdominal hypoperfusion 2.86 0.74 to 11.11
Age 1.02 0.97 to 1.08 Age 0.98 0.92 to 1.04
INR 3.60 1.29 to 10.06 INR 2.67 1.02 to 7.00
APACHE II score 1.14 1.02 to 1.26
Hospital mortality
Intra-abdominal hypertension 6.83 0.86 to 54.12 Abdominal hypoperfusion 2.44 0.38 to 6.67
Age 1.07 0.99 to 1.17 Age 1.05 0.97 to 1.14
INR 6.2 1.07 to 38.5 INR 6.36 0.92 to 44.22
APACHE II score 1.11 0.98 to 1.26
Renal replacement therapy
Intra-abdominal hypertension 6.78 1.29 to 35.70 Abdominal hypoperfusion 2.78 0.68 to 11.11
Age 0.92 0.92 to 1.04 Age 0.96 0.90 to 1.02
INR 2.06 0.98 to 4.32 APACHE 1.14 1.04 to 1.25
Child-Pugh score 0.51 0.30 to 0.90 Child-Pugh score 0.63 0.40 to 0.98
Creatinine 1.00 1.00 to 1.01
Variables used in the model were age, Child-Pugh score, Acute Physiology and Chronic Health Evaluation II score, creatinine, INR, fluid balance on day1 ,
hydrocortisone therapy and either the presence of intra-abdominal hypertension (mean intra-abdominal pressure ≥ 12 vs. < 12 mmHg) or abdominal
hypoperfusion (mean abdominal perfusion pressure < 60 vs. ≥ 60 mmHg) on first ICU admission day. Variables with p < 0.1 on stepwise multivariate logistic
regression analysis are reported in the table. APACHE, Acute Physiology and Chronic Health Evaluation; INR, international normalized ratio; RRT, renal replacement
therapy.
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Page 7 of 11with ultrafiltration [24]. Supporting organ function with
vasopressors and judicious goal-directed fluid resuscita-
tion to maintain an APP ≥ 50 to 60 mmHg has also
been advocated [24,35]. More invasive procedures
including percutaneous catheter decompression or drai-
nage and surgical decompression might be helpful, espe-
cially when IAP exceeds 25 mmHg [35]. Our study did
not assess the physiologic effects of interventions such
Variable  AUC  P value  95% CI 
APACHE 
II
0.71 0.02 0.56  - 0.85
MAP  0.60 0.24 0.44  - 0.76
ScvO2 0.59 0.30 0.43  - 0.74 
IAP  0.74 0.004  0.58  - 0.90 
APP  0.71 0.01 0.56  - 0.85
Figure 3 Receiver operating characteristic curve analysis for predictors of intensive care unit mortality. The variables studied are Acute
Physiology and Chronic Health Evaluation (APACHE) II score, mean arterial pressure, central venous oxygen saturation, intra-abdominal pressure
and abdominal perfusion pressure. These variables, except for APACHE II score, were the mean of measurements taken every 6 h on the first
admission day to the intensive care unit.
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Page 8 of 11as abdominal paracentesis or the prognostic implications
of IAH management.
Our findings should be interpreted in the light of the
strengths and limitations of the study. Strengths include
the prospective data collection, the IAP measurements
every 6 h by trained critical care nurses and the clearly
defined clinical outcomes. However, there are some lim-
itations. First, it was a single-center retrospective study.
Second, it had a small sample size. Nevertheless, our
patient population, cirrhotic patients with SS, is interest-
ing and merits additional research. Third, it lacked data
on the effect of ascites evacuation. Fourth, the intra-vesi-
cular pressure was measured using 50 to 100 ml of sterile
saline, which is too large and has been shown to overesti-
mate intra-vesicular pressure [37,38]. The current recom-
mendation is to use a maximum of 25 ml [23]; however,
the study began before such a recommendation was pub-
lished. Fifth, the use of the symphysis pubis as the zero
reference point is outdated. It is currently recommended
to zero the transducer at the mid-axillary line level
[23,39]. Although the study was conducted over a rela-
tively long period (2004 to 2007), clinical management
was standardized and followed a strict study protocol
and, therefore, unlikely to have affected outcomes.
In conclusion, IAH was at least a marker of increased
ICU morbidity and mortality in cirrhotic patients with
SS. Based on the physiologic effects of increased IAP,
IAH might even be a contributing factor to the develop-
ment of organ dysfunction and death in them. Whether
the IAH management improves the outcome of this
patient population needs to be further studied in a ran-
domized controlled trial. This future research is espe-
cially important considering that the prognosis of
cirrhotic patients who develop critical illness remains
poor despite aggressive therapy and advances in inten-
sive care.
Panel D 
P=0.47 
APP ≥55 mm Hg 
APP <55 mm Hg 
Panel B 
ScvO2 <70% 
ScvO2 ≥70% 
P=0.70  P=0.09 
MAP ≥65 mm Hg 
MAP <65 mm Hg 
Panel  A 
IAP ≥12 mm Hg 
IAP <12 mm Hg 
P=0.02 
Panel C 
Figure 4 Kaplan-Meier survival curves. For cirrhotic septic patients with mean arterial pressure ≥ 65 and < 65 mmHg (A), central venous
oxygen saturation ≥ 70% and < 70% (B), intra-abdominal pressure ≥ 12 and < 12 mmHg (C) and abdominal perfusion pressure ≥ 55 and < 55
mmHg (D). These resuscitation endpoints were the mean of measurements taken every 6 h on the first admission day to the intensive care unit.
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